Vericel Expects 2023 Revenue of About $197.5 Million, Up 20%, in Preliminary Results
Vericel said in a January 9, 2024 press release and updated investor presentation that full-year 2023 total net revenue is expected to be about $197.5 million, up 20%, with fourth-quarter revenue of about $65.0 million, up 23%. The figures are preliminary and unaudited, and the company warned that final results may differ materially. The company also reported about $152 million in cash, restricted cash and investments and no debt as of December 31, 2023.
Key points
- Full-year 2023 MACI net revenue expected at about $164.8 million, up 25%; Burn Care about $32.7 million
- Fourth-quarter 2023 total net revenue expected at about $65.0 million, up 23%; gross margin expected above 70%
- Full-year 2023 adjusted EBITDA margin expected in the mid-teens percentage range, with adjusted EBITDA growth of about 30%
- Results are preliminary and unaudited; the company's J.P. Morgan presentation is scheduled for January 10, 2024
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 09, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.